Efficacy of bezafibrate and fenofibrate on elevated blood lipids in HLP type IIa, IIb and IV
Schwartzkopff, W.; Luley, C.; Scheffler, W.; Lehmann-Leo, W.; Schilling, A.; Wegscheider, K.
Die Medizinische Welt 33(17): 631-637
1982
ISSN/ISBN: 0025-8512 PMID: 7098826 Document Number: 190971
Document emailed within 1 workday
Related Documents
Sznajderman, M. 1984: Comparison of the hypolipemic effects of bezafibrate and fenofibrate in patients with hyperlipoproteinemia type II and IV Przeglad Lekarski 41(7): 493-499Hobbs, T.; Caso, R.; McMahon, D.; Nymark, M. 2014: A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study Alternative Therapies in Health and Medicine 20(5): 18-23
Bolzano, K.; Krempler, F.; Schellenberg, B.; Schlierf, G. 1979: A comparison of bezafibrate and clofibrate in type Ii B and type IV hyperlipoproteinemia Acta Medica Austriaca 6(3): 90-94
Arntz, H.R.; Klemens, U.H.; Vollmar, L.J.; Lang, P.D. 1978: Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia Medizinische Klinik 73(49): 1731-1737
Turecký, L.; Laktis, K.; Uhlíková, E.; Kupcová, V.; Krizko, J. 1986: Blood lipids in acute type B viral hepatitis Bratislavske Lekarske Listy 85(5): 541-547
Heller, F.R.; Desager, J.P.; Harvengt, C. 1988: Changes in plasma activities of lipolytic enzymes and lipids of normolipidemic subjects given phenobarbital, a strong microsomal inducer, alone or in combination with fenofibrate International Journal of Clinical Pharmacology Therapy and Toxicology 26(3): 138-142
Fricker, J.; Douste-Blazy, P.; Drouin, P.; De Gennes, J.L.; Dachet, C.; Keller, U. 1990: The efficacy and tolerance of simvastatin and fenofibrate in primary hypercholesterolemia Presse Medicale 19(42): 1927-1930
Kozlov, S.G.; Dotsenko, I.V.; Sankova, A.V.; Liakishev, A.A.; Tvorogova, M.G.; Afanas'eva, O.I.; Titov, V.N.; Pokrovskiĭ, S.N.; Naumov, V.G. 2002: Effect of hormone replacement therapy on blood serum lipids in postmenopausal women with type 2 diabetes Kardiologiia 42(7): 47-52
Koanantakul, B.; Jeamanukulkit, N.; Piamsomboon, C.; Chawantanpipat, C.; Khanacharoen, I. 2004: Efficacy and safety of 12-week treatment with fenofibrate 300 mg in Thai dyslipidemic patients Journal of the Medical Association of Thailand 87(11): 1281-1285
Micheli, H.; Pometta, D.; Gustafson, A. 1980: Effects of fenofibrate in four types of hyperlipoproteinaemia and on apoproteins a and B in type IIa HLP La Nouvelle Presse Medicale 9(49): 3759-3762
Manojlović, D.; Lepsanović, L.; Micić, D.; Sumarac, M.; Kendereski, L.; Popović, V.; Mićić, J. 1991: Multicenter study of the efficacy and tolerance of gemfibrozil and fenofibrate in the treatment of primary hyperlipoproteinemia Srpski Arhiv Za Celokupno Lekarstvo 119(1-2): 22-25
Tabacchi, M.H.; Kirksey, A. 1973: Influence of dietary lipids on plasma and hepatic lipids and on blood clotting properties in rats fed oral contraceptives Journal of Nutrition 103(9): 1270-1278
Wessels, F. 2010: Is fenofibrate a cost-saving treatment for middle-aged individuals with type 2 diabetes? a South African private-sector perspective Cardiovascular Journal of Africa 21(1): 43-46
Hua, Q.; Tan, J.; Liu, Z-hui.; Liu, R-kun.; Yang, Z. 2007: A cohort study on the correlation between birth weight, simple obesity, blood lipids, blood glucose and blood pressure from childhood to adolescence Zhonghua Nei Ke Za Zhi 46(11): 923-925
Hottelart, C.; el Esper, N.; Achard, J.M.; Pruna, A.; Fournier, A. 1999: Fenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency Nephrologie 20(1): 41-44
Andreeva, L.S.; Leshchinskaia, E.V.; Martynenko, I.N. 1982: Diagnostic efficacy of the determination of antibodies against herpes simplex virus type i in the cerebrospinal fluid and blood of children with meningoencephalitis Pediatriia 4: 16-18
Ivanova, T.N.; Poliakova, E.D.; Olfer'ev, A.M.; Perova, N.V. 1998: Effect of micronized fenofibrate (lipantyl-200M) on synthesis of cholesterol in peripheral blood lymphocytes of patients with ischemic heart disease and hyperlipidemia Biulleten' Eksperimental'noi Biologii i Meditsiny 125(5): 569-573
Nichols, S.D.; Crichlow, H. 2010: An evaluation of the diagnostic utility of anthropometric and body composition cut-off values in assessing elevated fasting blood sugar and blood pressure West Indian Medical Journal 59(3): 253-258
Henningsen, N.C.; Lannsjö, H.W. 1980: Alcohol abstinence--effects on blood pressure, blood lipids and liver enzymes Lakartidningen 77(51): 4870-4871
Yang, Y.; Fu, L.; Wang, Z.; Wang, S.; Meng, X.; Ma, R.; Ma, D.; Ma, J. 2015: Mediating effect of blood lipids on correlation between body fat and blood pressure among overweight adults Zhonghua Liu Xing Bing Xue Za Zhi 36(7): 691-694